Managing FCS is notoriously difficult. With standard lipid-lowering therapies often failing, strict diet has historically been the only tool. In this CME program, Dr. Shapiro reviews the pathophysiology and strategies to reduce pancreatitis risk. Watch the full video ➡️ https://www.facebook.com/watch/live/?ref=watch_permalink&v=1171021224648318 #CME | Medscape

Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Are you ready for the transition to personalized therapy? Experts discuss the cutting-edge science in prostate cancer management. See how new research is identifying specific signaling pathways that drive growth and resistance to traditional AR-targeted therapy. Watch the full discussion ➡️ https://www.facebook.com/events/4220213341569914 #CME | Medscape